80
Participants
Start Date
February 28, 2011
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Placebo
Single-dose, 2 x microcrystalline cellulose (weighed to equal weights of average tablet/capsule of active comparator) mixed with 150 ml artificially sweetened, non-carbonated beverage
MS Contin (morphine sulfate, controlled release)
Single-dose, 2 x 60 mg morphine sulfate whole tablets manually crushed and mixed with 150 ml artificially sweetened, non-carbonated beverage
EMBEDA (morphine sulfate / naltrexone hydrochloride)
Single-dose, solution 2 x 60 mg morphine sulfate with sequestered 2.4 mg Naltrexone hydrochloride whole capsules manually crushed and mixed with 150 ml artificially sweetened, non-carbonated beverage
Lifetree Clinical Research, Salt Lake City
Lead Sponsor
Pfizer
INDUSTRY